Aggressive population-level management programmes targeting hypertension and diabetes may help curtail the rise of cardiovascular diseases (CVD) and associated deaths and disabilities in Singapore, according to a recent study.
The coexistence of diabetes mellitus (DM) in Asian patients with heart failure (HF) who were receiving cardiac resynchronization therapy (CRT) attenuated CRT-induced left ventricular (LV) reverse modelling — a predictor of event-free survival — and was associated with worse clinical outcomes compared with patients without T2D, the PEACH* study shows.
No association exists between a vegan diet and lower blood pressure (BP) measurements as compared with omnivorous alternatives, a study has found. The effect of a vegan diet in adults is similar to that by portion-controlled diets and those recommended by medical societies.
Prof. Rafael R. Castillo, Dr. Hyo Seung Ahn, 20190820000000
Major trials have demonstrated the benefits of beta-blockers in the treatment of hypertension.1 At a recent symposium held during the Asian Paciﬁc Society of Cardiology 2019 Congress in Manila, Philippines, experts discussed the latest guidelines on hypertension treatment, with a focus on the role of the 3rd generation beta-blocker, nebivolol. The symposium was chaired by Dr Dante D. Morales, Clinical Associate Professor at the University of the Philippines College of Medicine, and featured renowned cardiologists Prof Rafael R. Castillo and Dr Hyo Seung Ahn.
Treatment with off-label dose-reduced direct oral anticoagulants (DOACs) leads to reduced effectiveness with no safety benefit among patients with nonvalvular atrial fibrillation (AF), according to a study, suggesting that compliance with per-label dosage may significantly improve outcomes.
The CardioMEMS HF system, an ambulatory implantable hemodynamic monitor, is safe and useful for monitoring haemodynamic changes in patients with pulmonary arterial hypertension (PAH) and right-sided heart failure who are undergoing treatment, according to a study.
Early administration of recombinant human B-type natriuretic peptide (rhBNP) can lower the incidence of reperfusion injury for patients with ST-elevation myocardial infarction (STEMI) who are receiving percutaneous coronary intervention (PCI) treatment, according to a China study.
Untreated white coat hypertension (WCH), but not treated white coat effect (WCE), may increase the risk for cardiovascular events and all-cause mortality, suggest the results of a systematic review and meta-analysis. Out-of-office blood pressure (BP) monitoring is thus important in the diagnosis and management of hypertension.
Risk factors for 1-year mortality in heart failure (HF) patients significantly differ between those with and without chronic kidney disease (CKD), especially with regard to the use of beta-blockers or diuretics at discharge, according to a study. This suggests that these patients may benefit from individualized therapies.
Implementing the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guideline over that of the 2018 European Society of Cardiology/European Society of Hypertension (ESC/ESH) will give rise to a substantial increase in the prevalence of hypertension, as well as the number of adults who should receive medication, according to a study.